# Disturbed Flow Induces Reprogramming of Endothelial Cells to Immune-like and Foam Cells under Hypercholesterolemia during Atherogenesis

**Authors:** Christian Park, Kyung In Baek, Ruei-Chun Hung, Leandro Choi, Kiyoung Jeong, Paul Kim, Andrew Keunho Jahng, Jung Hyun Kim, Mostafa Meselhe, Ashwin Kannan, Chien-Ling Chou, Dong Won Kang, Eun Ju Song, Yerin Kim, Jay Aaron Bowman-Kirigin, Michael David Clark, Sander W. van der Laan, Gerard Pasterkamp, Nicolas Villa-Roel, Alyssa Panitch, Hanjoong Jo

PMC · DOI: 10.21203/rs.3.rs-4397799/v1 · Research Square · 2025-03-07

## TL;DR

The study shows that disturbed blood flow combined with high cholesterol causes endothelial cells to transform into immune-like and foam cells, contributing to atherosclerosis.

## Contribution

The study validates the two-hit hypothesis that disturbed flow and hypercholesterolemia together trigger full endothelial reprogramming into immune-like and foam cells.

## Key findings

- Disturbed flow and hypercholesterolemia together induce full endothelial reprogramming into immune-like and foam cells.
- Endothelial-derived foam cells share transcriptomic profiles with foam cells from smooth muscle cells and macrophages.
- Single-cell RNA sequencing and lineage-tracing confirm the novel FIRE hypothesis in atherosclerosis.

## Abstract

Atherosclerosis occurs preferentially in the arteries exposed to disturbed flow (d-flow), while the stable flow (s-flow) regions are protected even under hypercholesterolemic conditions. We recently showed that d-flow alone initiates flow-induced reprogramming of endothelial cells (FIRE), including the novel concept of partial endothelial-to-immune-cell-like transition (partial EndIT), but was not validated using a genetic lineage-tracing model. Here, we tested and validated the two-hit hypothesis that d-flow is an initial instigator of partial FIRE but requires hypercholesterolemia to induce a full-blown FIRE and atherosclerotic plaque development.

Mice were treated with adeno-associated virus expressing proprotein convertase subtilisin/kexin type 9 and a Western diet to induce hypercholesterolemia and/or partial carotid ligation (PCL) surgery to expose the left common carotid artery (LCA) to d-flow. Single-cell RNA sequencing (scRNA-seq) analysis was performed using cells obtained from the intima and leftover LCAs and the control right common carotid arteries at 2 and 4 weeks post-PCL. Comprehensive immunohistochemical staining was performed on EC-specific confetti mice treated with PCL and hypercholesterolemic conditions at 4 weeks post-PCL to validate endothelial reprogramming.

Atherosclerotic plaques developed by d-flow under hypercholesterolemia at 2 and 4 weeks post-PCL, but not by d-flow or hypercholesterolemia alone, as expected. The scRNA-seq results of 98,553 single cells from 95 mice revealed 25 cell clusters; 5 EC, 3 vascular smooth muscle cell (SMC), 5 macrophage (MΦ), and additional fibroblast, T cell, natural killer cell, dendritic cell, neutrophil, and B cell clusters. Our scRNA-seq analyses showed that d-flow under hypercholesterolemia transitioned healthy ECs to full immune-like (EndIT) and, more surprisingly, foam cells (EndFT), in addition to inflammatory and mesenchymal cells (EndMT). Further, EC-derived foam cells shared remarkably similar transcriptomic profiles with foam cells derived from SMCs and MΦs. Comprehensive lineage-tracing studies using immunohistochemical staining of canonical protein and lipid markers in the EC-specific confetti mice clearly demonstrated direct evidence supporting the novel FIRE hypothesis, including EndIT and EndFT, when d-flow was combined with hypercholesterolemia. Further, reanalysis of the publicly available human carotid plaque scRNA-seq and Perturb-seq datasets supported the FIRE hypothesis and a potential mechanistic link between the genes and FIRE.

We provide evidence supporting the two-hit hypothesis: ECs in d-flow regions, such as the branching points, are partially reprogrammed, while hypercholesterolemia alone has minimal endothelial reprogramming effects. Under hypercholesterolemia, d-flow fully reprograms arterial ECs, including the novel EndIT and EndFT, in addition to inflammation and EndMT, during atherogenesis. This single-cell atlas provides a crucial roadmap for developing novel mechanistic understanding and therapeutics targeting flow-sensitive genes, proteins, and pathways of atherosclerosis.

## Linked entities

- **Diseases:** atherosclerosis (MONDO:0005311)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** PCSK9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 255738] {aka FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1}
- **Diseases:** inflammation (MESH:D007249), Atherogenesis (MESH:D050197), atherosclerotic plaque (MESH:D058226), Hypercholesterolemia (MESH:D006937), hypercholesterolemic (MESH:D006938)
- **Chemicals:** lipid (MESH:D008055)
- **Species:** Adeno-associated virus (species) [taxon 272636], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11908347/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11908347/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC11908347/full.md

---
Source: https://tomesphere.com/paper/PMC11908347